Christopher Heery's Insider Trades & SAST Disclosures
Christopher Heery's most recent trade in Arcellx Inc was a trade of 22,556 Common Stock done . Disclosure was reported to the exchange on Feb. 24, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Christopher Heery.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
Showing you 100 results sorted by most recent dates.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2025 | 22,556 | 47,641 | - | 0 | Common Stock | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2025 | 22,556 | 0 | - | - | Restricted Stock Unit | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 64.26 per share. | 24 Feb 2025 | 5,577 | 37,694 | - | 64.3 | 358,360 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 63.14 per share. | 24 Feb 2025 | 4,370 | 43,271 | - | 63.1 | 275,918 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 64.88 per share. | 24 Feb 2025 | 208 | 37,486 | - | 64.9 | 13,495 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2025 | 22,556 | 47,641 | - | 0 | Common Stock | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2025 | 22,556 | 0 | - | - | Restricted Stock Unit | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 52,258 | 52,258 | - | - | Restricted Stock Unit | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 52,258 | 52,258 | - | - | Restricted Stock Unit | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2025 | 16,519 | 38,818 | - | 0 | Common Stock | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2025 | 16,519 | 16,520 | - | - | Restricted Stock Unit | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2025 | 16,519 | 38,818 | - | 0 | Common Stock | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2025 | 16,519 | 16,520 | - | - | Restricted Stock Unit | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2025 | 13,021 | 22,299 | - | 0 | Common Stock | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2025 | 13,021 | 26,042 | - | - | Restricted Stock Unit | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2025 | 13,021 | 22,299 | - | 0 | Common Stock | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2025 | 13,021 | 26,042 | - | - | Restricted Stock Unit | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 79.55 per share. | 02 Jan 2025 | 3,301 | 35,517 | - | 79.5 | 262,588 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 79.55 per share. | 02 Jan 2025 | 3,301 | 35,517 | - | 79.5 | 262,588 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 77.17 per share. | 02 Jan 2025 | 3,061 | 32,456 | - | 77.2 | 236,208 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 77.17 per share. | 02 Jan 2025 | 3,061 | 32,456 | - | 77.2 | 236,208 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Sep 2024 | 3,421 | 132,416 | - | - | Stock Option (right to buy) | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 70.02 per share. | 05 Sep 2024 | 3,421 | 9,278 | - | 70.0 | 239,526 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.00 per share. | 05 Sep 2024 | 3,421 | 12,699 | - | 15 | 51,315 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.00 per share. | 03 Sep 2024 | 22,000 | 31,278 | - | 15 | 330,000 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2024 | 22,000 | 135,837 | - | - | Stock Option (right to buy) | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 66.05 per share. | 03 Sep 2024 | 14,776 | 21,953 | - | 66.0 | 975,912 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 67.24 per share. | 03 Sep 2024 | 6,617 | 15,336 | - | 67.2 | 444,899 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2024 | 5,451 | 43,604 | - | - | Stock Option (right to buy) | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.28 per share. | 03 Sep 2024 | 5,451 | 36,729 | - | 6.3 | 34,232 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 70.07 per share. | 03 Sep 2024 | 2,900 | 9,278 | - | 70.1 | 203,202 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 68.01 per share. | 03 Sep 2024 | 1,958 | 13,378 | - | 68.0 | 133,168 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 69.06 per share. | 03 Sep 2024 | 1,200 | 12,178 | - | 69.1 | 82,872 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Aug 2024 | 21,684 | 157,837 | - | - | Stock Option (right to buy) | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.00 per share. | 26 Aug 2024 | 21,684 | 30,962 | - | 15 | 325,260 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 71.34 per share. | 26 Aug 2024 | 15,252 | 9,278 | - | 71.3 | 1,088,108 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 70.61 per share. | 26 Aug 2024 | 6,432 | 24,530 | - | 70.6 | 454,165 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 65.05 per share. | 16 Aug 2024 | 5,450 | 9,278 | - | 65.1 | 354,526 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.28 per share. | 16 Aug 2024 | 5,450 | 14,728 | - | 6.3 | 34,226 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Aug 2024 | 5,450 | 49,055 | - | - | Stock Option (right to buy) | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 60.39 per share. | 01 Aug 2024 | 19,268 | 10,010 | - | 60.4 | 1,163,689 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2024 | 10,684 | 179,521 | - | - | Stock Option (right to buy) | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.00 per share. | 01 Aug 2024 | 10,684 | 29,278 | - | 15 | 160,260 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.28 per share. | 01 Aug 2024 | 9,316 | 18,594 | - | 6.3 | 58,504 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2024 | 9,316 | 54,505 | - | - | Stock Option (right to buy) | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 61.13 per share. | 01 Aug 2024 | 732 | 9,278 | - | 61.1 | 44,746 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 65.30 per share. | 16 Jul 2024 | 10,901 | 9,278 | - | 65.3 | 711,854 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2024 | 10,901 | 63,821 | - | - | Stock Option (right to buy) | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.28 per share. | 16 Jul 2024 | 10,901 | 20,179 | - | 6.3 | 68,458 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.28 per share. | 11 Jul 2024 | 3,671 | 12,949 | - | 6.3 | 23,054 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jul 2024 | 3,671 | 76,502 | - | - | Stock Option (right to buy) | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 60.01 per share. | 11 Jul 2024 | 3,671 | 9,278 | - | 60.0 | 220,302 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jul 2024 | 1,780 | 74,722 | - | - | Stock Option (right to buy) | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 60.21 per share. | 11 Jul 2024 | 1,780 | 9,278 | - | 60.2 | 107,175 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.28 per share. | 11 Jul 2024 | 1,780 | 11,058 | - | 6.3 | 11,178 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 55.26 per share. | 01 Jul 2024 | 17,217 | 12,061 | - | 55.3 | 951,372 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.00 per share. | 01 Jul 2024 | 12,964 | 29,278 | - | 15 | 194,460 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2024 | 12,964 | 190,205 | - | - | Stock Option (right to buy) | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2024 | 7,036 | 80,173 | - | - | Stock Option (right to buy) | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.28 per share. | 01 Jul 2024 | 7,036 | 16,314 | - | 6.3 | 44,186 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 56.20 per share. | 01 Jul 2024 | 2,783 | 9,278 | - | 56.2 | 156,391 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 55.13 per share. | 12 Jun 2024 | 19,918 | 9,360 | - | 55.1 | 1,098,073 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jun 2024 | 12,036 | 203,169 | - | - | Stock Option (right to buy) | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.00 per share. | 12 Jun 2024 | 12,036 | 29,278 | - | 15 | 180,540 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.28 per share. | 12 Jun 2024 | 7,964 | 17,242 | - | 6.3 | 50,014 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jun 2024 | 7,964 | 87,209 | - | - | Stock Option (right to buy) | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 56.04 per share. | 12 Jun 2024 | 82 | 9,278 | - | 56.0 | 4,595 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.28 per share. | 01 May 2024 | 18,168 | 27,106 | - | 6.3 | 114,095 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 51.48 per share. | 01 May 2024 | 10,481 | 9,538 | - | 51.5 | 539,542 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2024 | 10,000 | 95,173 | - | - | Stock Option (right to buy) | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2024 | 8,168 | 10,901 | - | - | Stock Option (right to buy) | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 50.99 per share. | 01 May 2024 | 7,087 | 20,019 | - | 51.0 | 361,346 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 52.63 per share. | 01 May 2024 | 500 | 9,038 | - | 52.6 | 26,314 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 53.55 per share. | 01 May 2024 | 100 | 8,938 | - | 53.6 | 5,355 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 70.13 per share. | 22 Mar 2024 | 25,975 | 14,271 | - | 70.1 | 1,821,697 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.28 per share. | 22 Mar 2024 | 20,000 | 50,303 | - | 6.3 | 125,600 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 69.59 per share. | 22 Mar 2024 | 10,057 | 40,246 | - | 69.6 | 699,911 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Mar 2024 | 10,000 | 19,069 | - | - | Stock Option (right to buy) | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Mar 2024 | 10,000 | 110,623 | - | - | Stock Option (right to buy) | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Mar 2024 | 5,450 | 105,173 | - | - | Stock Option (right to buy) | |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.28 per share. | 22 Mar 2024 | 5,450 | 14,388 | - | 6.3 | 34,226 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 71.36 per share. | 22 Mar 2024 | 4,333 | 9,938 | - | 71.4 | 309,211 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 68.55 per share. | 22 Mar 2024 | 2,555 | 11,833 | - | 68.5 | 175,138 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 69.36 per share. | 22 Mar 2024 | 2,034 | 9,799 | - | 69.4 | 141,079 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 72.25 per share. | 22 Mar 2024 | 1,000 | 8,938 | - | 72.2 | 72,247 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 70.19 per share. | 22 Mar 2024 | 861 | 8,938 | - | 70.2 | 60,431 | Common Stock |
| Arcellx Inc | Heery Christopher | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 63.40 per share. | 08 Feb 2024 | 3,688 | 33,270 | - | 63.4 | 233,811 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 62.29 per share. | 08 Feb 2024 | 3,456 | 36,958 | - | 62.3 | 215,290 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 64.46 per share. | 08 Feb 2024 | 2,967 | 30,303 | - | 64.5 | 191,251 | Common Stock |
| Arcellx Inc | Christopher Heery | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2024 | 22,555 | 22,556 | - | - | Restricted Stock Unit | |
| Arcellx Inc | Heery Christopher | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2024 | 22,555 | 40,414 | - | 0 | Common Stock | |
| Arcellx Inc | Christopher Heery | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 55.27 per share. | 04 Jan 2024 | 7,598 | 17,859 | - | 55.3 | 419,926 | Common Stock |
| Arcellx Inc | Heery Christopher | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 60,096 | 60,096 | - | - | Stock Option (right to buy) | |
| Arcellx Inc | Christopher Heery | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 39,063 | 39,063 | - | - | Restricted Stock Unit | |
| Arcellx Inc | Christopher Heery | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2024 | 16,519 | 33,039 | - | - | Restricted Stock Unit | |
| Arcellx Inc | Heery Christopher | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2024 | 16,519 | 25,457 | - | 0 | Common Stock | |
| Arcellx Inc | Heery Christopher | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Dec 2023 | 120,000 | 120,623 | - | - | Stock Option (right to buy) | |
| Arcellx Inc | Heery Christopher | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.28 per share. | 18 Dec 2023 | 120,000 | 127,795 | - | 6.3 | 753,600 | Common Stock |
| Arcellx Inc | Christopher Heery | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 50.06 per share. | 18 Dec 2023 | 106,912 | 20,883 | - | 50.1 | 5,351,758 | Common Stock |
| Arcellx Inc | Christopher Heery | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 51.03 per share. | 18 Dec 2023 | 12,243 | 8,640 | - | 51.0 | 624,700 | Common Stock |
| Arcellx Inc | Heery Christopher | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 51.86 per share. | 18 Dec 2023 | 845 | 7,795 | - | 51.9 | 43,823 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges